FDA Inspection 1181478 — Laboratoires Clarins

Laboratoires Clarins — FEI 3002759467

The FDA completed an inspection of Laboratoires Clarins on Oct 14, 2022 in Pontoise. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 14, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pontoise (France)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
189021 CFR 211.165(e)Test methods
430321 CFR 211.67(b)Written procedures fail to include

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.